Physician profile
Stuart Feinstein
NPI 1154366763
$1,354.94
in general payments reported to CMS, 2019-2025
11 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $133 · 2021: $134 · 2022: $203 · 2023: $280 · 2024: $167 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $339.51 | 2019-2024 | |
| Glaxosmithkline, LLC. | $282.47 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $235.82 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Cranial Technologies, INC | $163.87 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $111.13 | 2021-2024 | |
| Abbott Laboratories | $104.16 | 2023 | Id Now Instrument |
| Global Blood Therapeutics, INC. | $41.12 | 2020-2022 | |
| Seqirus USA INC | $26.63 | 2023 | Flucelvax Quadrivalent |
| Genentech USA, INC. | $17.62 | 2020 | |
| Cognoa, INC. | $17.08 | 2021 | |
| Alk-Abello, INC | $15.53 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Feinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.